Scarica l'app Stockscreener
1.66
6.07%
0.095
Dopo l'orario di chiusura:
1.60
-0.06
-3.61%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché INBS Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.565
Aprire:
$1.58
Volume 24 ore:
104.51K
Relative Volume:
0.95
Capitalizzazione di mercato:
$9.74M
Reddito:
$3.19M
Utile/perdita netta:
$-10.42M
Rapporto P/E:
-0.0468
EPS:
-35.4757
Flusso di cassa netto:
$-10.65M
1 W Prestazione:
+17.73%
1M Prestazione:
+38.33%
6M Prestazione:
-0.60%
1 anno Prestazione:
-20.57%
Intervallo 1D:
$1.58
$1.70
Intervallo di 1 settimana:
$1.3531
$1.70
Portata 52W:
$1.00
$3.00
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Nome
Intelligent Bio Solutions Inc
Settore
Industria
Telefono
646-233-6971
Indirizzo
135 W 41ST ST,, NEW YORK
Confronta INBS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.66 | 9.74M | 3.19M | -10.42M | -10.65M | -35.48 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Intelligent Bio Solutions Inc Borsa (INBS) Ultime notizie
Intelligent Bio Solutions (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows - TipRanks
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows - Yahoo Finance
Healthcare's Quiet AI Boom Is Creating a New Class of Breakout Contenders - The Globe and Mail
Intelligent Bio Solutions Advances Innovative Fingerprint Drug Testing Technology Toward U.S. Market - citybuzz -
Intelligent Bio Solutions (NASDAQ: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference - TipRanks
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference - Yahoo Finance
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing a - GuruFocus
Intelligent Bio Solutions (INBS) to Showcase Drug Testing System at RISE25 | INBS Stock News - GuruFocus
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing - The Manila Times
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing | INBS Stock News - GuruFocus
Intelligent Bio Solutions Inc. to Showcase Drug Testing Innovation at RISE25 Conference with Partner SMARTOX - Nasdaq
Revolutionary 10-Minute Fingerprint Drug Test Targets US Forensic Market at RISE25 Conference - Stock Titan
Intelligent Bio Solutions Expands Global Reach with Multilingual Digital Strategy - citybuzz -
INBS Expands Workforce Drug Testing with Successful Remote Opera - GuruFocus
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Tes - GuruFocus
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment | INBS Stock News - GuruFocus
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment - The Manila Times
Intelligent Bio Solutions Inc. Successfully Conducts High-Volume Workforce Drug Testing for Barcaldine Regional Council in Queensland, Australia - Nasdaq
Revolutionary 10-Minute Fingerprint Drug Test Transforms Workplace Screening: 160 Workers Tested Before Breakfast - Stock Titan
4 Top Cybersecurity Stocks to Buy in May - The Globe and Mail
Intelligent Bio Solutions (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally - The Globe and Mail
Intelligent Bio Solutions Expands Global Operations - TipRanks
Intelligent Bio Solutions (INBS) Achieves Significant Growth wit - GuruFocus
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally - Yahoo Finance
Intelligent Bio Solutions (INBS) Achieves Significant Growth with New Accounts and Technology | INBS Stock News - GuruFocus
Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing - The Manila Times
Intelligent Bio Solutions Inc. Reports Significant Growth Across Global Operations with Over 450 Active Accounts and Expansion into New Sectors - Nasdaq
Fingerprint Drug Testing Revolution: How Intelligent Bio Solutions Captured 450+ Global Accounts in 24 Countries - Stock Titan
Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Res - GuruFocus
Intelligent Bio Solutions Reports Strong Q3 2025 Results - TipRanks
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins - Yahoo Finance
Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements - ADVFN
Intelligent Bio Solutions (NASDAQ: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins - Barchart.com
Intelligent Bio Solutions (INBS) Sees Revenue Dip but Focuses on Strategic Growth | INBS Stock News - GuruFocus
INTELLIGENT BIO SOLUTIONS INC. SEC 10-Q Report - TradingView
EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91% - Benzinga
Intelligent Bio Solutions (NASDAQ: INBS) Is ‘One to Watch’ - The Globe and Mail
bioAffinity Technologies Boosts Data Acquisition for CyPath Lung Test - Medical Product Outsourcing
Intelligent Bio Solutions (INBS) Expands Global Presence with Ne - GuruFocus
Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion | INBS Stock News - GuruFocus
Intelligent Bio Solutions (INBS) Expands Global Presence with New Websites | INBS Stock News - GuruFocus
Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion - The Manila Times
Intelligent Bio Solutions Targets $1.1B Market with Global Drug Testing Expansion in Arabic, Spanish Markets - Stock Titan
Texas Capital Bancshares, Inc. (NASDAQ:TCBI) Given Average Rating of “Hold” by Analysts - American Banking and Market News
Intelligent Bio Solutions Adds Latin American Spanish To Drug Screening System To Expand Reach - Nasdaq
Intelligent Bio Solutions (INBS) Expands Language Options in Dru - GuruFocus
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System | INBS Stock News - GuruFocus
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System - The Manila Times
Intelligent Bio Solutions Expands Drug Screening Reach: Eyes Massive $1.1B Latin American Market Opportunity - Stock Titan
XTX Topco Ltd Buys New Position in Credit Acceptance Co. (NASDAQ:CACC) - American Banking and Market News
Intelligent Bio Solutions Files For Mixed Shelf Of Up To $100 MillionSEC Filing - MarketScreener
Intelligent Bio Solutions Inc Azioni (INBS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.56%
1.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):